Christian Cho-Hua Lee

Title: Christian Cho-Hua Lee: Innovator in Antibody and Kinase Inhibitor Technologies

Introduction

Christian Cho-Hua Lee is a prominent inventor based in San Diego, CA. He has made significant contributions to the fields of biotechnology and pharmaceuticals, particularly in the development of antibodies and kinase inhibitors. With a total of 4 patents, his work has the potential to impact various therapeutic areas.

Latest Patents

Lee's latest patents include innovative technologies related to ENTPD2 antibodies and combination therapies. These patents provide antibodies or antigen-binding fragments that specifically bind to the human ENTPD2 protein. The methods outlined in these patents also describe the use of these antibodies in combination with additional therapeutic agents. Furthermore, he has developed novel pyrimidine derivatives and pharmaceutical compositions that serve as kinase inhibitors. These compounds may be utilized to treat conditions responsive to the inhibition of insulin-like growth factor (IGF-1R) or anaplastic lymphoma kinase (ALK).

Career Highlights

Throughout his career, Christian Cho-Hua Lee has worked with notable companies such as Irm LLC and Novartis AG. His experience in these organizations has allowed him to refine his expertise in drug development and therapeutic innovations.

Collaborations

Lee has collaborated with esteemed colleagues, including Thomas H. Marsilje, III, and Wenshuo Lu. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Christian Cho-Hua Lee is a distinguished inventor whose work in antibody and kinase inhibitor technologies holds promise for future medical advancements. His contributions continue to shape the landscape of biotechnology and pharmaceuticals.